Edition:
United Kingdom

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

2.16USD
19 Oct 2018
Change (% chg)

$0.01 (+0.47%)
Prev Close
$2.15
Open
$2.15
Day's High
$2.24
Day's Low
$2.11
Volume
47,320
Avg. Vol
125,848
52-wk High
$10.40
52-wk Low
$2.06

Chart for

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $387.58
Shares Outstanding(Mil.): 36.22
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -2.29 -- --
ROI: -50.00 0.45 14.28
ROE: -52.94 1.37 16.00

BRIEF-Newlink Genetics Corp Reports Qtrly Loss Per Share Of $0.49

* NEWLINK GENETICS CORP QTRLY BASIC AND DILUTED LOSS PER SHARE $0.49

03 May 2018

BRIEF-Newlink Genetics Appoints Matthew Sherman To Board

* NEWLINK GENETICS - IN CONNECTION WITH APPOINTMENT OF MATTHEW SHERMAN TO CO'S BOARD, BOARD WILL BE COMPRISED OF EIGHT DIRECTORS Source text for Eikon: Further company coverage:

01 May 2018

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,888 +19.00
Pfizer Inc. (PFE.N) $44.50 +0.50
Novartis AG (NOVN.S) CHF87.04 +1.16
Merck & Co., Inc. (MRK.N) $72.35 +0.14
Roche Holding Ltd. (ROG.S) CHF244.95 +6.40
Roche Holding Ltd. (RO.S) CHF245.20 +5.80
Abbott Laboratories (ABT.N) $67.59 -0.55
Sanofi SA (SASY.PA) €77.80 0.00
AstraZeneca plc (AZN.L) 5,934.00 +56.00
GlaxoSmithKline plc (GSK.L) 1,557.60 +47.00

Earnings vs. Estimates